capiton AG
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity
Stage Focus
Buyout, Growth
Geographical Focus
Germany, Switzerland, Austria
Industries Focus
- Healthcare & Life Sciences
- High-Tech Industrials
Investment Size:
20,000,000 to 60,000,000 USD
Investor Details Founded: 1999
An established private equity firm specializing in management buy-outs and growth financing for medium-sized companies in the DACH region.
Capiton AG focuses on profitable companies with annual revenues between €50 million and €300 million, primarily in the High-Tech Industrials and Healthcare & Life Sciences sectors.
With over 200 years of combined experience, the team has supported more than 80 companies, achieving an average annual EBITDA growth of 18%.
Requirements
- Profitable medium-sized companies with annual revenues between €50 million and €300 million in the High-Tech Industrials and Healthcare & Life Sciences sectors.
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Addvance Group
- AEMtec GmbH
- AlphaPet Ventures GmbH & Healthfood24 GmbH
- Asyril SA
- Axxence Group
- BWTS GmbH
- CEDES AG
- CymbiQ Group AG
- Dec Group
- EVP / Vitafy
- HCD Healthcare & Diagnostics GmbH
- KD Pharma Group
- MIP
- Raith GmbH
- Solvis GmbH
- Wundex Group
Mentioned In
-
$19.95
-
$39.95
-
$245.00
Claim this Investor
Are you an official representative of capiton AG?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim